
See exactly how BIOIX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BIOIX and 80,000+ other tickers.
This investment vehicle primarily commits capital to common equities issued by fast-growing American companies, irrespective of their market valuation, identified for their robust potential for value growth. The portfolio manager holds the prerogative to back enterprises across diverse economic sectors and industries, particularly those perceived to gain considerably from pioneering technological developments and innovation.
No recent news available.